[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Global & China Cancer mTOR Inhibitors Market Research by Company, Type & Application 2015-2026

January 2020 | 99 pages | ID: C9169EEC7282EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

HeyReport estimates that the Cancer mTOR Inhibitors market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.

In this report, HeyReport discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Cancer mTOR Inhibitorsindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.

Market Segment as follows:

Product Type Segmentation Includes
  • Afinitor/Votubia
  • Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
  • Torisel (Temsirolimus)
  • Evertor andndash
Application Segmentation Includes
  • Breast Cancer
  • Hematological Malignancy
  • Neuroendocrine Tumors
  • Hepatocellular Carcinoma
  • Glioblastoma
Companies Includes
  • Abraxis BioScience
  • Adimab
  • Celgene Corporation
  • Celator Pharmaceuticals
  • Eli Lilly
  • Exelixis
  • GlaxoSmithKline
  • HEC Pharm
  • Intellikine
  • Novartis
  • Oneness Biotech
  • PIQUR Therapeutics
  • Semafore Pharmaceuticals
  • Takeda
  • Wyeth
The main contents of the report including:

Section 1:
Product definition, type and application, Global & China market overview;
Section 2:
Global & China Market competition by company;
Section 3:
Global & China sales revenue, volume and price by type;
Section 4:
Global & China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact HeyReport for customized contents.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Afinitor/Votubia
    1.1.2.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
    1.1.2.3 Torisel (Temsirolimus)
    1.1.2.4 Evertor andndash
  1.1.3 Market by Application
    1.1.3.1 Breast Cancer
    1.1.3.2 Hematological Malignancy
    1.1.3.3 Neuroendocrine Tumors
    1.1.3.4 Hepatocellular Carcinoma
    1.1.3.5 Glioblastoma
1.2 Global & China Market Size & Forecast
  1.2.1 Global Market (2015-2020 & 2021-2026)
  1.2.2 China Market (2015-2020 & 2021-2026)

2 GLOBAL & CHINA MARKET BY COMPANY

2.1 Global Sales by Company
2.2 China Sales by Company

3 GLOBAL & CHINA MARKET BY TYPE

3.1 Global Sales by Product Type
3.2 China Sales by Product Type

4 GLOBAL & CHINA MARKET BY APPLICATION

4.1 Global Sales by Application
4.2 China Sales by Application

5 CHINA TRADE

5.1 Export Overview
5.2 Import Overview

6 KEY COMPANIES LIST

6.1 Abraxis BioScience
  6.1.1 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Adimab
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Celgene Corporation
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Celator Pharmaceuticals
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eli Lilly
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Exelixis
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 GlaxoSmithKline
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 HEC Pharm
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Intellikine
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Novartis
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Oneness Biotech
  6.11.1 Company Information
  6.11.2 Product Specifications
  6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 PIQUR Therapeutics
  6.12.1 Company Information
  6.12.2 Product Specifications
  6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Semafore Pharmaceuticals
  6.13.1 Company Information
  6.13.2 Product Specifications
  6.13.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.14 Takeda
  6.14.1 Company Information
  6.14.2 Product Specifications
  6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.15 Wyeth
  6.15.1 Company Information
  6.15.2 Product Specifications
  6.15.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Upstream Overview

8 POLICIES & MARKET ENVIRONMENT

8.1 Policies
  8.1.1 Major Regions Policies
  8.1.2 Policies in China
8.2 Market Environment
  8.2.1 Porter's Five Forces
  8.2.2 Impact of COVID-19

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2015-2020
Table Global Market Sales Revenue Share by Company 2015-2020
Table Global Market Sales Volume by Company 2015-2020
Table Global Market Sales Volume Share by Company 2015-2020
Table Global Price by Company 2015-2020
Table China Market Sales Revenue by Company 2015-2020
Table China Market Sales Revenue Share by Company 2015-2020
Table China Market Sales Volume by Company 2015-2020
Table China Market Sales Volume Share by Company 2015-2020
Table China Price by Company 2015-2020
Table Global Market Sales Revenue by Type 2015-2020
Table Global Market Sales Revenue Share by Type 2015-2020
Table Global Market Sales Volume by Type 2015-2020
Table Global Market Sales Volume Share by Type 2015-2020
Table Global Price by Type 2015-2020
Table China Market Sales Revenue by Type 2015-2020
Table China Market Sales Revenue Share by Type 2015-2020
Table China Market Sales Volume by Type 2015-2020
Table China Market Sales Volume Share by Type 2015-2020
Table China Price by Type 2015-2020
Table Global Market Sales Revenue by Application 2015-2020
Table Global Market Sales Revenue Share by Application 2015-2020
Table Global Market Sales Volume by Application 2015-2020
Table Global Market Sales Volume Share by Application 2015-2020
Table Global Price by Application 2015-2020
Table China Market Sales Revenue by Application 2015-2020
Table China Market Sales Revenue Share by Application 2015-2020
Table China Market Sales Volume by Application 2015-2020
Table China Market Sales Volume Share by Application 2015-2020
Table China Price by Application 2015-2020
Table China Export 2015-2020 (Million USD)
Table China Export 2015-2020 (Volume)
Table China Import 2015-2020 (Million USD)
Table China Import 2015-2020 (Volume)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Abraxis BioScience
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Adimab
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Celgene Corporation
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Celator Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Exelixis
Table Sales Revenue, Salels Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Salels Volume, Price, Cost and Margin of HEC Pharm
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Intellikine
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Oneness Biotech
Table Sales Revenue, Salels Volume, Price, Cost and Margin of PIQUR Therapeutics
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Semafore Pharmaceuticals
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Takeda
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Wyeth


LIST OF FIGURES

Figure Afinitor/Votubia Market Size and Growth 2015-2020 (Million USD)
Figure Afinitor/Votubia Market Size and Growth 2015-2020 (Volume)
Figure Afinitor/Votubia Market Forecast and Growth 2021-2026 (Million USD)
Figure Afinitor/Votubia Market Forecast and Growth 2021-2026 (Volume)
Figure Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Size and Growth 2015-2020 (Million USD)
Figure Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Size and Growth 2015-2020 (Volume)
Figure Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Forecast and Growth 2021-2026 (Million USD)
Figure Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor Market Forecast and Growth 2021-2026 (Volume)
Figure Torisel (Temsirolimus) Market Size and Growth 2015-2020 (Million USD)
Figure Torisel (Temsirolimus) Market Size and Growth 2015-2020 (Volume)
Figure Torisel (Temsirolimus) Market Forecast and Growth 2021-2026 (Million USD)
Figure Torisel (Temsirolimus) Market Forecast and Growth 2021-2026 (Volume)
Figure Evertor andndash Market Size and Growth 2015-2020 (Million USD)
Figure Evertor andndash Market Size and Growth 2015-2020 (Volume)
Figure Evertor andndash Market Forecast and Growth 2021-2026 (Million USD)
Figure Evertor andndash Market Forecast and Growth 2021-2026 (Volume)
Figure Breast Cancer Market Size and Growth 2015-2020 (Million USD)
Figure Breast Cancer Market Size and Growth 2015-2020 (Volume)
Figure Breast Cancer Market Forecast and Growth 2021-2026 (Million USD)
Figure Breast Cancer Market Forecast and Growth 2021-2026 (Volume)
Figure Hematological Malignancy Market Size and Growth 2015-2020 (Million USD)
Figure Hematological Malignancy Market Size and Growth 2015-2020 (Volume)
Figure Hematological Malignancy Market Forecast and Growth 2021-2026 (Million USD)
Figure Hematological Malignancy Market Forecast and Growth 2021-2026 (Volume)
Figure Neuroendocrine Tumors Market Size and Growth 2015-2020 (Million USD)
Figure Neuroendocrine Tumors Market Size and Growth 2015-2020 (Volume)
Figure Neuroendocrine Tumors Market Forecast and Growth 2021-2026 (Million USD)
Figure Neuroendocrine Tumors Market Forecast and Growth 2021-2026 (Volume)
Figure Hepatocellular Carcinoma Market Size and Growth 2015-2020 (Million USD)
Figure Hepatocellular Carcinoma Market Size and Growth 2015-2020 (Volume)
Figure Hepatocellular Carcinoma Market Forecast and Growth 2021-2026 (Million USD)
Figure Hepatocellular Carcinoma Market Forecast and Growth 2021-2026 (Volume)
Figure Glioblastoma Market Size and Growth 2015-2020 (Million USD)
Figure Glioblastoma Market Size and Growth 2015-2020 (Volume)
Figure Glioblastoma Market Forecast and Growth 2021-2026 (Million USD)
Figure Glioblastoma Market Forecast and Growth 2021-2026 (Volume)
Figure Global Cancer mTOR Inhibitors Market Size and Growth 2015-2020 (Million USD)
Figure Global Cancer mTOR Inhibitors Market Size and Growth 2015-2020 (Volume)
Figure Global Cancer mTOR Inhibitors Market Forecast and Growth 2021-2026 (Million USD)
Figure Global Cancer mTOR Inhibitors Market Forecast and Growth 2021-2026 (Volume)
Figure China Cancer mTOR Inhibitors Market Size and Growth 2015-2020 (Million USD)
Figure China Cancer mTOR Inhibitors Market Size and Growth 2015-2020 (Volume)
Figure China Cancer mTOR Inhibitors Market Forecast and Growth 2021-2026 (Million USD)
Figure China Cancer mTOR Inhibitors Market Forecast and Growth 2021-2026 (Volume)
Figure Global Market Sales Revenue Share by Company in 2019
Figure Global Market Sales Volume Share by Company in 2019
Figure China Market Sales Revenue Share by Company in 2019
Figure China Market Sales Volume Share by Company in 2019
Figure Global Market Sales Revenue Share by Type in 2019
Figure Global Market Sales Volume Share by Type in 2019
Figure China Market Sales Revenue Share by Type in 2019
Figure China Market Sales Volume Share by Type in 2019
Figure Global Market Sales Revenue Share by Application in 2019
Figure Global Market Sales Volume Share by Application in 2019
Figure China Market Sales Revenue Share by Application in 2019
Figure China Market Sales Volume Share by Application in 2019
Figure Industry Chain Overview


More Publications